financetom
Business
financetom
/
Business
/
JPMorgan Chase Board Planning CEO Transition; Says President, COO Daniel Pinto 'Immediately Ready' If Needed
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
JPMorgan Chase Board Planning CEO Transition; Says President, COO Daniel Pinto 'Immediately Ready' If Needed
Apr 8, 2024 7:18 AM

09:49 AM EDT, 04/08/2024 (MT Newswires) -- JPMorgan Chase ( JPM ) has identified President and Chief Operating Officer Daniel Pinto as 'immediately ready' to lead the banking giant as chief executive "should the need arise in the near-term," according to a Monday filing with the Securities and Exchange Commission.

The bank said planning for an orderly CEO transition in the medium term is among the top priorities of its board, which is "spending significant time" developing candidates "who are well-known to shareholders" as potential successors to CEO Jamie Dimon.

"We view Mr. Pinto as a key executive who is immediately ready to fulfill the responsibilities of the CEO," Dimon and Lead Independent Director Stephen Burke said in a letter to shareholders in the filing. "We also continue to develop a deep bench of potential leaders who can execute the firm's strategy and enhance our strong culture."

Price: 198.13, Change: +0.68, Percent Change: +0.34

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Abivax Says Ulcerative Colitis Drug Maintained Clinical Remission at Reduced Dose
Abivax Says Ulcerative Colitis Drug Maintained Clinical Remission at Reduced Dose
Oct 3, 2024
04:13 AM EDT, 10/03/2024 (MT Newswires) -- Abivax ( ABVX ) said Thursday an interim analysis from its open-label maintenance study showed that patients with ulcerative colitis maintained clinical remission while taking its obefazimod drug at a reduced dose for up to two additional years. Patients who initially took 50 milligrams of obefazimod daily were allowed to continue treatment at...
Housing to Improve in 2025 as Bank of Canada Rate Cuts to Drive
Housing to Improve in 2025 as Bank of Canada Rate Cuts to Drive "Modest" Upturn, Says Macquarie Economist
Oct 3, 2024
09:11 AM EDT, 09/25/2024 (MT Newswires) -- Canada's housing has been stagnant in recent months as prices have meandered, home sales have stalled and renovation activity has been sluggish, said David Doyle, head of economics at Macquarie. One bright spot has been an improvement in the trend in starts, noted Doyle. In the near term, the economist anticipates sideways activity...
OncoCyte Enters Into $10.2 Million Private Placement Agreement
OncoCyte Enters Into $10.2 Million Private Placement Agreement
Oct 3, 2024
04:12 AM EDT, 10/03/2024 (MT Newswires) -- OncoCyte ( OCX ) said late Wednesday that it had signed a securities purchase agreement with new and existing investors, including strategic partner Bio-Rad Laboratories ( BIO/B ) , to raise about $10.2 million through a private placement. Proceeds from the private placement, expected to close on Oct. 4, will be used for...
BGC Group Extends $500 Million Senior Notes Exchange Offer
BGC Group Extends $500 Million Senior Notes Exchange Offer
Oct 3, 2024
09:16 AM EDT, 09/25/2024 (MT Newswires) -- BGC Group ( BGC ) said Wednesday it has extended its offer to swap up to $500 million total principal amount of its outstanding 6.6% senior notes due 2029 for newly registered notes with identical terms. The offer will now expire at 5 pm ET on Friday, according to the company. A total...
Copyright 2023-2026 - www.financetom.com All Rights Reserved